Role of tryptase in immediate cutaneous responses in allergic sheep

J. F. Molinari, W. R. Moore, J. Clark, R. Tanaka, J. H. Butterfield, W. M. Abraham

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

In this study, we used a specific tryptase inhibitor, APC-366 [N-(1- hydroxy-2-napthoyl)-L-arginyl-L-prolinamide hydrochloride] to investigate the effect of intradermally administered tryptase and tryptase released by antigen challenge on the immediate cutaneous reaction (ICR) in allergic sheep. The surface areas of cutaneous wheals produced by intradermal injections (0.05 ml) of 1 and 10 ng tryptase alone, tryptase combined with 3 U heparin (tryptase-heparin), or Ascaris suum antigen (10-5 dilution) with or without pretreatment with APC-366 (1 mg/ml) were measured at 20 and 60 min after challenge. Intradermal injections of 1 and 10 ng tryptase alone (n = 7) produced an ICR of ≤20% of that obtained after injection of histamine (5% wt/vol). Intradermal injection of tryptase-heparin (n = 7), however, resulted in 50 (1 ng) and 82% (10 ng) of the ICR to histamine (both, P < 0.05 vs. tryptase alone). APC-366 inhibited (P < 0.05) the ICR to 1 and 10 ng tryptase-heparin by ≥70% at all times (n = 8) but had no effect on the histamine-induced ICR (n = 3). A combination of the histamine H1 antagonist chlorpheniramine (2 mg/kg iv) and the H2 antagonist metiamide (3 mg/kg iv) given 40 min before challenge (n = 8) inhibited the response to 1 and 10 ng tryptase-heparin by 42 and 62% at 20 min and by 96 and 86% at 60 min, respectively (all, P < 0.05). APC-366 also blocked the ICR to A. suum antigen by 68% (P < 0.05) in nine sheep. These results indicate that intradermal injection of tryptase-heparin can induce an ICR. This ICR can be inhibited by APC-366 or a combination of the histamine H1 and H2 antagonists, suggesting that the tryptase response is mediated by histamine. APC-366 also blocks the mast cell-mediated ICR to intradermally injected A. suum antigen. Collectively, these results suggest that tryptase may modulate mast cell histamine release.

Original languageEnglish
Pages (from-to)1966-1970
Number of pages5
JournalJournal of Applied Physiology
Volume79
Issue number6
StatePublished - Dec 1 1995
Externally publishedYes

Fingerprint

Tryptases
Sheep
Skin
Intradermal Injections
Heparin
Ascaris suum
Histamine
Histamine H1 Antagonists
Antigens
Mast Cells
Metiamide
Histamine H2 Antagonists
Chlorpheniramine
Histamine Release
N-(1-hydroxy-2-naphthoyl)arginyl-prolinamide

Keywords

  • asthma
  • inflammatory mediators
  • mast cells
  • serine proteases
  • tryptase antagonists

ASJC Scopus subject areas

  • Physiology
  • Endocrinology
  • Orthopedics and Sports Medicine
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

Molinari, J. F., Moore, W. R., Clark, J., Tanaka, R., Butterfield, J. H., & Abraham, W. M. (1995). Role of tryptase in immediate cutaneous responses in allergic sheep. Journal of Applied Physiology, 79(6), 1966-1970.

Role of tryptase in immediate cutaneous responses in allergic sheep. / Molinari, J. F.; Moore, W. R.; Clark, J.; Tanaka, R.; Butterfield, J. H.; Abraham, W. M.

In: Journal of Applied Physiology, Vol. 79, No. 6, 01.12.1995, p. 1966-1970.

Research output: Contribution to journalArticle

Molinari, JF, Moore, WR, Clark, J, Tanaka, R, Butterfield, JH & Abraham, WM 1995, 'Role of tryptase in immediate cutaneous responses in allergic sheep', Journal of Applied Physiology, vol. 79, no. 6, pp. 1966-1970.
Molinari JF, Moore WR, Clark J, Tanaka R, Butterfield JH, Abraham WM. Role of tryptase in immediate cutaneous responses in allergic sheep. Journal of Applied Physiology. 1995 Dec 1;79(6):1966-1970.
Molinari, J. F. ; Moore, W. R. ; Clark, J. ; Tanaka, R. ; Butterfield, J. H. ; Abraham, W. M. / Role of tryptase in immediate cutaneous responses in allergic sheep. In: Journal of Applied Physiology. 1995 ; Vol. 79, No. 6. pp. 1966-1970.
@article{0cff005be04c4cbb9072399090e5e026,
title = "Role of tryptase in immediate cutaneous responses in allergic sheep",
abstract = "In this study, we used a specific tryptase inhibitor, APC-366 [N-(1- hydroxy-2-napthoyl)-L-arginyl-L-prolinamide hydrochloride] to investigate the effect of intradermally administered tryptase and tryptase released by antigen challenge on the immediate cutaneous reaction (ICR) in allergic sheep. The surface areas of cutaneous wheals produced by intradermal injections (0.05 ml) of 1 and 10 ng tryptase alone, tryptase combined with 3 U heparin (tryptase-heparin), or Ascaris suum antigen (10-5 dilution) with or without pretreatment with APC-366 (1 mg/ml) were measured at 20 and 60 min after challenge. Intradermal injections of 1 and 10 ng tryptase alone (n = 7) produced an ICR of ≤20{\%} of that obtained after injection of histamine (5{\%} wt/vol). Intradermal injection of tryptase-heparin (n = 7), however, resulted in 50 (1 ng) and 82{\%} (10 ng) of the ICR to histamine (both, P < 0.05 vs. tryptase alone). APC-366 inhibited (P < 0.05) the ICR to 1 and 10 ng tryptase-heparin by ≥70{\%} at all times (n = 8) but had no effect on the histamine-induced ICR (n = 3). A combination of the histamine H1 antagonist chlorpheniramine (2 mg/kg iv) and the H2 antagonist metiamide (3 mg/kg iv) given 40 min before challenge (n = 8) inhibited the response to 1 and 10 ng tryptase-heparin by 42 and 62{\%} at 20 min and by 96 and 86{\%} at 60 min, respectively (all, P < 0.05). APC-366 also blocked the ICR to A. suum antigen by 68{\%} (P < 0.05) in nine sheep. These results indicate that intradermal injection of tryptase-heparin can induce an ICR. This ICR can be inhibited by APC-366 or a combination of the histamine H1 and H2 antagonists, suggesting that the tryptase response is mediated by histamine. APC-366 also blocks the mast cell-mediated ICR to intradermally injected A. suum antigen. Collectively, these results suggest that tryptase may modulate mast cell histamine release.",
keywords = "asthma, inflammatory mediators, mast cells, serine proteases, tryptase antagonists",
author = "Molinari, {J. F.} and Moore, {W. R.} and J. Clark and R. Tanaka and Butterfield, {J. H.} and Abraham, {W. M.}",
year = "1995",
month = "12",
day = "1",
language = "English",
volume = "79",
pages = "1966--1970",
journal = "Journal of Applied Physiology",
issn = "8750-7587",
publisher = "American Physiological Society",
number = "6",

}

TY - JOUR

T1 - Role of tryptase in immediate cutaneous responses in allergic sheep

AU - Molinari, J. F.

AU - Moore, W. R.

AU - Clark, J.

AU - Tanaka, R.

AU - Butterfield, J. H.

AU - Abraham, W. M.

PY - 1995/12/1

Y1 - 1995/12/1

N2 - In this study, we used a specific tryptase inhibitor, APC-366 [N-(1- hydroxy-2-napthoyl)-L-arginyl-L-prolinamide hydrochloride] to investigate the effect of intradermally administered tryptase and tryptase released by antigen challenge on the immediate cutaneous reaction (ICR) in allergic sheep. The surface areas of cutaneous wheals produced by intradermal injections (0.05 ml) of 1 and 10 ng tryptase alone, tryptase combined with 3 U heparin (tryptase-heparin), or Ascaris suum antigen (10-5 dilution) with or without pretreatment with APC-366 (1 mg/ml) were measured at 20 and 60 min after challenge. Intradermal injections of 1 and 10 ng tryptase alone (n = 7) produced an ICR of ≤20% of that obtained after injection of histamine (5% wt/vol). Intradermal injection of tryptase-heparin (n = 7), however, resulted in 50 (1 ng) and 82% (10 ng) of the ICR to histamine (both, P < 0.05 vs. tryptase alone). APC-366 inhibited (P < 0.05) the ICR to 1 and 10 ng tryptase-heparin by ≥70% at all times (n = 8) but had no effect on the histamine-induced ICR (n = 3). A combination of the histamine H1 antagonist chlorpheniramine (2 mg/kg iv) and the H2 antagonist metiamide (3 mg/kg iv) given 40 min before challenge (n = 8) inhibited the response to 1 and 10 ng tryptase-heparin by 42 and 62% at 20 min and by 96 and 86% at 60 min, respectively (all, P < 0.05). APC-366 also blocked the ICR to A. suum antigen by 68% (P < 0.05) in nine sheep. These results indicate that intradermal injection of tryptase-heparin can induce an ICR. This ICR can be inhibited by APC-366 or a combination of the histamine H1 and H2 antagonists, suggesting that the tryptase response is mediated by histamine. APC-366 also blocks the mast cell-mediated ICR to intradermally injected A. suum antigen. Collectively, these results suggest that tryptase may modulate mast cell histamine release.

AB - In this study, we used a specific tryptase inhibitor, APC-366 [N-(1- hydroxy-2-napthoyl)-L-arginyl-L-prolinamide hydrochloride] to investigate the effect of intradermally administered tryptase and tryptase released by antigen challenge on the immediate cutaneous reaction (ICR) in allergic sheep. The surface areas of cutaneous wheals produced by intradermal injections (0.05 ml) of 1 and 10 ng tryptase alone, tryptase combined with 3 U heparin (tryptase-heparin), or Ascaris suum antigen (10-5 dilution) with or without pretreatment with APC-366 (1 mg/ml) were measured at 20 and 60 min after challenge. Intradermal injections of 1 and 10 ng tryptase alone (n = 7) produced an ICR of ≤20% of that obtained after injection of histamine (5% wt/vol). Intradermal injection of tryptase-heparin (n = 7), however, resulted in 50 (1 ng) and 82% (10 ng) of the ICR to histamine (both, P < 0.05 vs. tryptase alone). APC-366 inhibited (P < 0.05) the ICR to 1 and 10 ng tryptase-heparin by ≥70% at all times (n = 8) but had no effect on the histamine-induced ICR (n = 3). A combination of the histamine H1 antagonist chlorpheniramine (2 mg/kg iv) and the H2 antagonist metiamide (3 mg/kg iv) given 40 min before challenge (n = 8) inhibited the response to 1 and 10 ng tryptase-heparin by 42 and 62% at 20 min and by 96 and 86% at 60 min, respectively (all, P < 0.05). APC-366 also blocked the ICR to A. suum antigen by 68% (P < 0.05) in nine sheep. These results indicate that intradermal injection of tryptase-heparin can induce an ICR. This ICR can be inhibited by APC-366 or a combination of the histamine H1 and H2 antagonists, suggesting that the tryptase response is mediated by histamine. APC-366 also blocks the mast cell-mediated ICR to intradermally injected A. suum antigen. Collectively, these results suggest that tryptase may modulate mast cell histamine release.

KW - asthma

KW - inflammatory mediators

KW - mast cells

KW - serine proteases

KW - tryptase antagonists

UR - http://www.scopus.com/inward/record.url?scp=0029614666&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029614666&partnerID=8YFLogxK

M3 - Article

C2 - 8847261

AN - SCOPUS:0029614666

VL - 79

SP - 1966

EP - 1970

JO - Journal of Applied Physiology

JF - Journal of Applied Physiology

SN - 8750-7587

IS - 6

ER -